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Epidemiological studies have shown that human adults have a higher chance of 
developing various metabolic disorders, such as type II diabetes and hypertension, due to 
maternal under nutrition.  The concept that conditions encountered in early development can 
have far reaching implications for an individual’s adult life is known as the Developmental 
Origins of Health and Disease (DOHaD) hypothesis. In vitro studies have shown that if the amino 
acid leucine is not available at a high enough concentration the embryo will not exhibit normal 
trophectoderm protrusive activity which precedes implantation. The amino acid transport 
system System B
0,+
 is the main gateway into these cells for leucine but its expression at the 
transcription level has never been shown in preimplantation blastocysts. We investigated 
System B
0,+
 expression in preimplantation blastocysts from dams fed a control versus a low-
protein isocaloric diet (18% and 9% casein, respectively).  Using RT-PCR to detect the System 
B
0,+
 transcript,  ATB
0,+
, we found that indeed there is expression of this amino acid transporter 
in the pre-implantation rat blastocyst. Due to the gender-specific nature of many DOHaD 
phenomena, the blastocysts were sexed using gender specific primers and a nested PCR 
approach.  Quantitative real time PCR (qRT-PCR) results show no significant difference in ATB
0,+
 
expression in blastocysts taken from dams fed either diet (9% n= 56, 18% n = 52; 7 dams from 
each diet group).  Furthermore, separating the data by gender reveals no significant difference 
in expression. However, while not significant, there does appear to be a trend in the protein 
restricted blastocysts towards increased transcription of ATB
0,+
,  suggesting System B
0,+
 may be 
responding at the transcription level to the diet. This could be part of the predictive adaptive 
response leading to a reprogrammed phenotype as described by the DOHaD hypothesis.  
Further work is needed to elucidate System B
0,+
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Adult late-onset diseases, such as type II diabetes and hypertension,  have been linked to 
sub-optimal growth conditions encountered during early development (i.e. in utero or in vitro).  
Low birth weight, an indicator of poor gestational conditions, is a predictor for a variety of late-
onset adult diseases. These include: type II diabetes, hypertension, obesity, and many others. 
These conditions have been grouped into a condition known as “metabolic syndrome” [1-3].  
An estimated 25% of the American population has metabolic syndrome [1].  Research indicates 
that people with metabolic syndrome are three times more likely to die of cardiovascular 
complications [4].  
Epidemiological research by Barker et al. in 1986 established the link between maternal 
under nutrition and increased adult disease rates.  When examining epidemiological data from 
post World War II England, Barker noticed low birth weight correlated with cardiovascular 
disease rates in the adults born during that same time period [5]. He theorized that poor 
nutrition in pre-natal life increases susceptibility to the effects of an affluent lifestyle. An 
affluent lifestyle, in this context, is an abundance of high energy and low cost food.  This has 
come to be known as the thrifty phenotype, and is the most common example of the 
developmental programming phenomenon. 
Developmental programming describes the elevated disease risks encountered by an 
individual when there is a mismatch between its pre-natal and postnatal nutritional conditions. 
For example, a thrifty phenotype individual has been developmentally programmed by poor 
nutrient conditions in utero to expect poor nutrient conditions for the duration of its life. This is 
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a survival advantage if nutrient conditions remain poor after birth. However, if that individual 
encounters a nutrient rich environment throughout postnatal life the in utero programming 
becomes detrimental and the individual develops obesity and metabolic syndrome. The 
diagram below summarizes the thrifty phenotype phenomenon. 
 
Figure 1. The “Thrifty Phenotype.” Offspring developing in nutrient poor environments tend 
towards metabolic syndrome and obesity when placed in a nutrient rich environment after 
birth. However if the postnatal nutritional environment remains poor the thrifty phenotype is a 
survival advantage [6]. 
 Barker’s observations opened a new and exciting area of research.  If pre-natal nutrition 
can have such a drastic effect on adult-life disease susceptibility then the implications are 
tremendous. The Developmental Origins of Health and Disease (DOHaD) hypothesis proposes 
that sub-optimal intrauterine environment, like that found during maternal under-nutrition, 
may alter the embryo’s development through predictive adaptive responses. These predictive 
adaptive responses are thought to be physiological adaptations made by the embryo in 
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response to a given maternal environment to best utilize available resources in utero and to 
prepare itself for postnatal life. If there is a mismatch between the in utero diet and postnatal 




1.1 Rodent Models for Developmental Programming 
 There are many species currently being used to examine developmental programming 
and this topic has been reviewed by Bertram et al. [7], Nathanielsz et al. [8] and McMullen et al. 
[9]. The species used include rats, mice, guinea pigs, sheep and non-human primates [7].  Rats 
are the most common animal model for many reasons: their development under normal 
conditions is well understood and documented, rats are small and economical to house, rats 
are easier to handle than mice, they have a short gestation period [7] and the rodent 
placentation style is similar to our own [10].  The disadvantages of using a small-animal model 
such as the rat are that they are dissimilar to humans in the following ways: they have a large 
litter size, rats are born physiologically immature, the diets fed to rodents are not completely 
equivalent to human dietary patterns and rodent disease symptoms and progression differ 
somewhat from their human counterparts [9].  
Most developmental programming models involve dietary manipulation of the mother 
during pregnancy. Several dietary regimes linked to the metabolic syndrome have been 
investigated, and they involve deficiencies or overabundances in macronutrient (protein, 
carbohydrates and fatty acids) concentrations of the diet.  Offspring of dams fed a high-fat diet 
suffered from hypertension when fed a normal diet after birth [11].  Woodall et al. fed rats a 
globally nutrient-restricted diet (50% of normal caloric content) during pregnancy and found 
the offspring rapidly gained weight during weaning, became overweight and suffered from 
cardiac hypertrophy and altered CV function in adult-hood [12]. A maternal low protein diet 
programs for reduced offspring birth weight and hypertension and many other programming 
effects covered below in section 1.2.  Vickers et al. showed that global nutrient restriction and 
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low protein in utero programs rat offspring to be sedentary and prone to increased adipose 
tissue formation, which is exacerbated by high energy diets [13].     
In addition to changes in macronutrient concentration there are other programming 
models. Iron deficiency [14] and calcium deficiency [15] during pregnancy in rats programs the 
offspring for hypertension. In mice, zinc deficiency during pregnancy programmed the offspring 
(and two subsequent generations) for immunodeficiency [16].  Exposure to elevated levels of 
glucocorticoids (from maternal stress or exogenous sources) is associated with reduced birth 
weight and development of metabolic syndrome in adulthood [7, 9].   Chronic maternal hypoxia 
during pregnancy programs offspring to be vulnerable to cardiovascular disease, by way of 
suppressing fetal cardiac function, altered cardiac gene expression, increased myocyte 
apoptosis, myocyte hypertrophy and cell cycle disruptions of myocytes [17].  Over 50 genes are 
affected by the maternal hypoxia model, as reviewed by Zhang et al. [17], including genes 
involved in the oxidative stress response pathway, cell signaling/survival genes, metabolism and 
neurotransmitters. Uterine artery ligation is a model used to simulate impaired nutrient 
perfusion though the placenta [18], reviewed by Fernandez-Twinn et al. [19].  Unilateral or 
bilateral uterine artery ligation results in: low birth weight offspring, reduced beta cell mass at 
birth persisting through adulthood leading to type II diabetes, decreased nephron number and 
renal function and a decrease in glomerular number resulting in compensatory glomerular 
enlargement [19].   
1.1.1 Developmental Programming Model - Maternal Low Protein Diet 
One of the most common models used to investigate the DOHaD hypothesis is the 
maternal low protein diet (MLP) model.  It is important to note that there are two low protein 
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diet regimes in the available literature. Langley-Evans compared them in 2000 [20].  The 
“Southampton” diet uses a control diet with 18% casein and a 9% casein diet to achieve normal 
and low protein conditions, respectively.  Casein is protein supplement derived from milk. 
The MLP model programs offspring for a wide variety of symptoms and at-risk 
phenotypes.  It lowers offspring birth weight, increases postnatal growth rate, causes 
hypertension, altered organ/bodyweight ratios, reduced cell numbers during the blastocyst 
phase of development [21], altered imprinted gene expression [22],  altered cardiac gene 
expression [23], altered pancreatic beta-cell gene expression [24], accelerated rates of renal 
failure in adult life [25] and a shorter offspring lifespan [26] perhaps due to increased 
susceptibility to oxidative stress [27]. The MLP model also appears to program rat offspring 
behavior; rats exposed to a low protein diet during gestation show a marked preference for 
high-fat food over control rats [28].  It is important to note that the models listed above are 
merely highlights taken from a long list of examples. In every example additional work is 
required to dissect and understand the mechanisms at work during the observed fetal 
programming.  One particularly interesting phenomenon of the fetal programming story is the 
gender-specific manner in which offspring are affected. 
1.1.2 Gender Specific Programming 
The effects seen in the offspring of the MLP model appear to be gender specific.  For 
example, under the MLP conditions, female (but not male) offspring birth weight is reduced 
[21].  [29].  Female offspring from the same study showed elevated Glut-2 and insulin mRNA 
levels [29]. An increase in systolic pressure and abnormal organ/body mass ratios in male (but 
not female) offspring were also observed [21].  Maternal low protein conditions generate male 
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offspring with a reduced beta-cell mass, reduced insulin content and marked glucose 
intolerance upon reaching adult-hood   Adult male offspring from MLP conditions showed 
reduced insulin-stimulated glucose uptake in both muscle and adipose tissue and a decrease in 
both GLUT 4 and PKC-ζ protein levels in muscle [30].  In another MLP study adipocytes isolated 
from 6 week old male offspring displayed increased insulin receptor expression and at 3 months 
male offspring adipocytes were found to be more responsive to insulin stimulation of glucose 
uptake [31]. 
Other programming models exhibit gender-specific effects.  Adult male offspring (but not 
female offspring) of endotoxic dams were heavier and showed increased adipose tissue 
formation, increased food intake, elevated circulating leptin, increased insulin resistance and 
reduced corticosterone in response to stress.  In contrast, adult females of endotoxic dams had 
the following symptoms:  increased testosterone levels, higher baseline corticosterone levels, 
enlarged heart:body mass ratio and enlarged adrenal glands [19].  Glucocorticoid-exposed 
offspring also demonstrate a gender-specific effect; males exhibit a typical metabolic syndrome 
phenotype (low birth weight, obese as adults, hypertension, hyperphagia, insulin resistance, 
etc.) whereas females are merely hypertensive and have a large increase in type-2 angiotensin 
receptor expression [19]. This might explain the observed renal remodeling and hypertension in 
these rats [19]. McCormick et al. noticed sex-specific effects of prenatal stress provided by 
electric shock; female offspring had elevated hypothalamic-pituitary-adrenal responses to 
stress, but males seemed unaffected [32].  High-fat fed dams yield offspring with gender 
specific effects; adult male offspring are more hyperinsulinemic during an oral glucose 
challenge than females [33].  Male offspring of high-fat fed dams also had a higher liver 
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triglyceride content than female offspring and their pattern of insulin signaling protein 
expression was consistent with reduced liver insulin sensitivity [19]. McMullen et al. observed 
gender-specific effects of prenatal low-protein and carbenoxolone exposure on renal 
angiotensin receptor expression levels; the female offspring showed a marked upregulation in 
expression when compared to males [34].  
The gender specific effects observed in the various developmental programming models 
remain difficult to explain.  In general, males appear to be more adversely affected by sub-
optimal developmental environments than females. Male pre-implantation embryos develop 
more quickly than female ones [35].    In vitro produced male embryos have a higher metabolic 
rate, grow faster and have differential transcription of genes on the sex chromosomes and the 
autosomal chromosomes than their female counterparts [36].  In mouse blastocysts over 600 
genes are differentially expressed based on gender [37].  It has been proposed that some genes 
expressed on the Y-chromosome may accelerate growth of preimplantation embryos, while 
expression of some X-chromosome products retard development [36].  A female embryo, 
having two X-chromosomes and no Y-chromosomes, would have none of the Y-chromosome 
genes which accelerate growth.   It is possible that male pre-implantation embryos ignore the 
uterine nutrient conditions (at their own peril) in order to maximize growth rates.  Female 
preimplantation embryos, having a slower growth rate, lower metabolism and different gene 
expression profile may cause them to be less affected (or unaffected) by some sub-optimal 
developmental conditions, as their growth rates may remain in step with the lowered nutrient 
availability.   This tentative explanation is consistent with the literature which shows males and 
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females are differentially affected by the various DOHaD models during development, with 
males being the more fragile of the two.   
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1.2 Early Rodent Development 
Fertilization occurs in the ampulla region of the oviduct. As the zygote moves down the 
oviduct and into the uterus, it progresses through serial cleavages (every 12-24 hours) from one 
cell to the morula stage (~12-30 cells) and then on to the early blastocyst stage [38].  Figure 2, 
below, illustrates this. Blastocysts have a unique feature, a blastocoel, which is a fluid filled 
central cavity which morulae lack. A blastocyst also has a distinct inner-cell mass (ICM) and 
trophectoderm (TE) which give rise to the embryo and extra-embryonic structures respectively.  
This loss of totipotency is an important milestone in development.  Once mature, blastocysts 
will hatch out of the zona and rapidly expand. This is an important landmark that precedes 
implantation.  If the maternal environment is receptive, the implantation process begins [39].  
 
Figure 2. The Early Stages of Rat Embryo Development. [38] The developing embryo at the 2-





1.2.1.1 The Attachment Phase 
After a blastocyst has hatched out of its zona it begins the attachment phase of 
implantation [40].  Implantation in rodents occurs on the antimesometrial side of the uterus 
[38]. Within a few hours of the trophectoderm cells making contact with the uterine epithelium 
there is an increase in vascular permeability of the stromal cells underlying the conceptus [41].  
Then, the intracellular matrix between uterine stromal cells changes as well as the stromal cell 
morphology [42].  This is known as the primary decidualization reaction [40].  The secondary 
decidualization reaction occurs 2-3 days later and involves similar processes over a much larger 
region of the endometrium as it prepares for placentation [43]. After the attachment phase is 
complete, the conceptus burrows itself into the endometrium; this process is known as 
penetration or invasion.  
1.2.1.2 The Invasive Phase 
The invasive stage of implantation occurs only in primates, rodentia and carnivora (cats, 
dogs, etc.) [40].  After the attachment phase, uterine epithelial cells are removed as giant 
trophoblasts engulf and digest them. The decidual tissue and uterine glandular tissue 
neighbouring this invasion site are also digested, releasing nutrients which are taken up by the 
conceptus [44, 45].  There is also rapid proliferation of trophectodermal cells into the spaces 
between uterine epithelial cells.  These trophoblast cells will continue to divide and 
differentiate, becoming the “Träger”, a cluster of cells which are a precursor to the placenta. At 
the leading edge of the invasion, giant trophoblasts will continue to phagocytize decidual cells 
until an ingrowth of allantoic vessels and cells develops and becomes the placental labyrinth. As 
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more and more of the uterine cells are removed, the conceptus buries itself deeper into the 
uterine wall. Eventually it is almost completely encompassed on all sides. Then, alongside the 
uterine cells, the trophectoderm cells divide and differentiate into the extra embryonic tissues 
that will support gestation until birth. 
1.2.2 Embryonic Genome Activation 
Before implantation and placentation many key developmental milestones must be 
reached.  One major developmental transition after fertilization is embryonic genome 
activation (EGA).  Following fertilization the development of the embryo is directed by proteins 
and transcripts inherited from the oocyte. EGA gradually transitions the control of development 
away from maternally inherited proteins and transcripts to zygotic ones. EGA is also known as 
zygotic genome activation (ZGA) or the maternal to zygotic transition (MZT). This topic has been 
reviewed extensively by Schultz et al. [46, 47] and Minami et al. [48]. Most research regarding 
EGA has been done in mice; where EGA has occurs at the 2-cell stage [47]. Blocking RNA 
synthesis in mice embryos with the chemical agent α-amanitin results in normal cellular 
cleavages occur until the 4-cell stage and then development ceases, demonstrating that 
maternal products are controlling development for the first few cleavages [48].  Newly 
synthesized transcripts and the resultant proteins do not take full control until the maternal 
transcripts and proteins are exhausted [47].  
There are three components of EGA.  First, oocyte-specific mRNAs that are no longer 
necessary are destroyed [47]. This restricts the period of time in which maternal genes can be 
expressed and thus prevents expression of proteins which are no longer necessary.  Secondly, 
maternally inherited transcripts that are still necessary for development are replaced with 
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zygotic transcripts from the newly created zygotic nucleus [46].  Lastly, new transcripts that are 
not expressed in the oocyte are also created at this time due to changes to the gene expression 
profile via the creation of the chromatin-based transcriptionally repressive state. This 
transcriptionally repressive state is set in place to block expression of nonessential genes and to 
enhance expression of genes important for further development of the embryo [47, 48].  
Many thousands of genes are activated during EGA [49].   These include genes involved 
in: cell cycle signaling, protein synthesis, DNA replication, DNA repair, DNA recombination, 
control of expression for other genes, cellular assembly and organization, carbohydrate 
metabolism, protein degradation, lipid metabolism, and many others.  Many genes involved in 
the transport of external substrates and nutrients are also transcribed at this time.  Glucose 
transporters GLUT1, GLUT2 and GLUT3 are all active during this period [50].  The cationic amino 
acid transporter System Y+ (Slc7a3), the proton/peptide transporter Slc15a2, the 
monocarboxylic acid transporter Slc16a1, and many others are also actively transcribed at this 
time [51]. The zinc transporter Znt1 has been proven crucial to pre- and post-implantation 
development and is transcribed during EGA [52].  The transcript for the amino acid transporter 
LAT-1, which is responsible for transport of large neutral amino-acids, is present in the zygote 
(as a maternal transcript) but from EGA onwards LAT-1 transcription increases with the 
strongest expression during blastocyst hatching [53]. 
1.2.3 The Epigenetics of Early Development 
Setting up the transcriptionally repressive state, mentioned above, is an alternate way 
of saying setting up the epigenetic control over the genome.  The embryonic DNA must be 
configured such that most genes are silenced by a tight chromatin structure and a few select 
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genes are not.  Prior to fertilization, both the male and female pronuclei are densely packaged 
for storage and are, for the most part, transcriptionally inert [47, 48].  Following fertilization the 
pronuclei are unpackaged and combined into a new zygotic genome.  The chromatin of this 
newly created zygotic genome is then tightly configured to silence the majority of the genome. 
The male pronucleus is packaged with protamines rather than histones [48], which are rapidly 
degraded and replaced with new histones following fertilization. These histones are more 
highly acetylated than those in maternal chromatin, allowing transcription of some genes 
before the pronuclei are combined.  Highly acetylated chromatin is transcriptionally active; thus 
early transcription of paternally inherited genes is greater than maternally inherited ones.   
However, until the late 1-cell stage, the majority of zygotic genes are silenced.  Then, by 
removing the silencing on a select genes, development proceeds forward in a tightly organized 
manner, with one gene leading to expression of others, and those genes leading to expression 
of still others [47].   
Genes can be silenced by many different mechanisms. CpG sequences on the genomic 
DNA itself can be methylated; causing a tighter chromatin structure and excluding the 
transcription machinery from accessing that gene, preventing transcription [54]. In addition to 
direct DNA methylation, there are proteins which are associated with genomic DNA, organizing 
it into bundles called nucleosomes. These proteins are known as histones, and they can be 
methylated, acetylated and/or phosphorylated to change the chromatin structure and either 
promote or discourage transcription [55].  Failure and/or improper reprogramming of the 
epigenetic machinery has been implicated in a broad range of diseases, including many cancers 
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[56], imprinting diseases [57] (discussed below),  and diseases linked  to suboptimal 
developmental conditions [58-60].  
During mammalian development the methylation pattern of the genome is laid down in 
two distinct stages [60].   The first is a major DNA demethylation event which occurs during 
primordial germ cell differentiation. This event erases DNA methylation-based silencing on all 
imprinted and single copy genes. Proper methylation of all imprinted genes is then established. 
Then, after fertilization, the second phase occurs. This phase occurs during preimplantation 
development and it strips the methylation of all non-imprinted genes. The methylation of those 
genes is then reestablished [61] and multi-copy genes are silenced (for example those on the 
second X-chomosome in females) [60].  By the morula stage there is a low methylation status of 
the entire genome, and subsequent differentiation into one of the two possible cell types (TE or 
ICM) involves epigenetic reprogramming (including methylation) of the genome resulting in cell 
type specific expression [58].  For example, in the ICM de novo remethylation occurs due to 
preferential nuclear localization of DNA methyltransferase 3b (Dnmt3b) [58].  Most of the 
epigenetics research has been on DNA methylation; unfortunately most of the changes 
occurring at the histone level during these events remain unknown [58, 60]. 
1.2.3.1 Epigenetics and Fetal Programming 
It has been demonstrated that during this burst of epigenetic activity the 
preimplantation embryo is sensitive to perturbations in its environment.  This has been 
reviewed by Dolinoy et al. [62] and Burdge et al. [63].  This sensitivity can lead to changes in the 
epigenetic programming, altering the gene expression pattern during development. This altered 
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expression has been linked to various diseases and may be causing the phenotypes described in 
the DOHaD literature.  
The epigenetics of a developing embryo can be altered in vivo by nutritional conditions. 
The viable yellow agouti (A
vy
) mouse is a classic model for the epigenetic effects of nutrition.  
Normally transiently expressed in hair follicles during a specific stage of hair growth, agouti 
encodes a signaling molecule that causes yellow hair pigmentation when ectopically expressed 
in A
vy
  mice [64].  Maternal methyl supplementation from extra folic acid, Vitamin B12, choline 
and betaine causes hypermethylation of the agouti gene, silencing the ectopic expression of 
agouti and restoring a normal brown phenotype in offspring [62].  Hypomethylation of the 
agouti gene causes the yellow phenotype.     
Manipulation of the macromolecule concentrations in the maternal diet can cause 
epigenetic programming in developing fetuses. For example, a maternal high-fat diet caused 
acetylation of fetal hepatic histone 3 in Japanese macaque offspring and a 40% change in 
transcription of glutamic pyruvate transaminase 2 (GPT2), Hsp70 co-chaperone DNAJA2 and 
retinol dehydrogenasse 12 (Rdh12) [65].  A protein restricted diet induces hypomethylation of 
the peroxisomal proliferator-activated receptor-alpha promoter region (PPARα) and 
glucocorticoid receptor (GR) promoter region causing increased transcription of these genes in 
rat offspring livers [66] and this shift in the metabolic phenotype of the offspring has been 
linked to hypertension [63].  In addition, the MLP diet causes hypomethylation of the promoter 
region of the angiotensin II receptor (AT1b) gene in offspring adrenal glands and suggests a 
direct link between epigenetic modifications due to in utero nutritional conditions and 
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hypertension [67]. Therefore, changes in the concentrations of either key nutrients or entire 
macromolecule classes during pregnancy can cause epigenetic changes in developing 
individuals leading to disease-prone reprogrammed adult phenotypes. 
In vitro fertilization (IVF) research has provided more insights into the epigenetic 
reprogramming of embryos that can occur during early development.  IVF studies in sheep and 
cows suggest the prevalence of abnormal placental growth and perinatal mortality are higher in 
IVF embryos than in naturally fertilized embryos [58].  This work lead to studies using early 
bovine and sheep embryos which showed that gene expression is altered due to perturbations 
in the nutritional content of the media, including addition of fetal calf serum, resulting in 
disruptions in organ and skeletal development [58].  Culture oxygen concentrations are also 
important, reducing them during in vitro culturing of sheep embryos caused an increased 
proportion of ICM cells and altered gene expression of GLUT1, a transmembrane glucose 
transporter [68].   Techniques such as intracytoplasmic sperm injection and round spermatid 
injection can induce aberrant DNA methylation patterns in rabbit and mouse blastocysts [60].  
A study by Li et al. has shown that the IVF procedure and certain culture media can cause 
abnormal DNA methylation and histone methylation, resulting in abnormal imprinting [69].  
While highly controversial, epidemiological evidence in humans suggests than some of the 
artificial reproductive technologies may be associated with an increased risk of epigenetic 
disorders resulting in low birth weight, imprinting related diseases (more on imprinted related 
diseases below in 3.3.2)  and congenital malformations [58].  
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1.2.3.2 Imprinted Genes and Fetal Programming 
Imprinted genes are a small but very important subset of genes whose alleles have been 
shown to be preferentially silenced based on their parent of origin.  They have only been 
described in metatherians (marsupials) [70], eutherians (placental mammals) [71] and 
angiosperms (flowering plants) [72].  Many imprinted genes modulate fetal growth and 
development and can influence placental function [73]. Paternally expressed imprinted genes 
increase the transfer of nutrients to the fetus, promoting growth, and maternally expressed 
imprinted genes decrease nutrient transfer to the fetus, conserving maternal resources for 
future offspring [74]. Imprinted genes appear to be more sensitive to the environmental 
conditions encountered in utero and have been implicated in disease susceptibility [75, 76].  
Genomic imprinting is an important part of the balancing act that is fetal growth regulation.  
The fetus must be afforded every chance to reach its genetic potential, but the mother’s 
resources must not be depleted beyond her ability to recuperate [74].  A change in imprinted 
gene expression could affect placental function and could therefore alter fetal growth and 
cause fetal programming.  
There are two well described imprinted genes, H19 and Insulin-like growth factor 2 
(Igf2).  H19 is a long non-coding RNA paternally methylated in normal imprinting; meaning the 
maternal copy of the allele is expressed and the paternal copy is silenced.  Igf2 is a growth 
factor similar in structure to insulin and is maternally silenced in normal imprinting [77]. H19 
has been linked to the suppression of Igf2 expression [78] and deletion of the H19 allele causes 
offspring to be about 27% heavier than wild-type [78]. Much of the research into imprinted 
genes centers on pathologies that occur when both alleles of an imprinted gene are active, 
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known as a “loss-of-imprinting”, wherein both the paternal and maternal allele are expressed 
[58-60].  Both Igf2 and H19 have been implicated in Beckwith-Wiedemann syndrome, an over-
growth disorder associated with a high risk of cancer [79].  
Maternal protein restriction during early development can cause changes in the 
expression of imprinted genes. In particular, Kwong et al. have identified changes in H19 and 
Igf2 when dams were exposed to a low protein diet during the first 4 days of gestation [22]. 
They found that male offspring had a 30% reduction in H19 mRNA at day 4 of gestation.  They 
also found that exposure to the maternal low protein diet for the first 4 days of gestation 
followed by a normal diet caused male day 20 fetal H19 and Igf2 mRNA levels to be 10% lower 
than normal.  To investigate the methylation status of H19, fetal liver DNA was examined. No 
changes at the differentially methylated region, described by the H19 imprinting literature, 
were noted, suggesting the imprinting of H19 was unaltered. However, no other DNA CpG 
regions and histone modifications were investigated [22]. Changes in expression of these genes 
is thought to be responsible for the observations by the same group that a maternal low 
protein diet during preimplantation gestation programs the offspring for hypertension [21, 22]. 
In vitro studies have shown that culture media can also affect changes in imprinted gene 
expression [58-60].  
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1.3 Amino Acids, Their Transporters and Amino Acid Signaling 
1.3.1 Amino Acids 
 There are nine essential amino acids required by human adults: histidine, isoleucine, 
leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine [80].  These amino 
acids cannot be synthesized in the body and must be consumed in the form of protein, which is 
chemically and enzymatically broken down in the stomach and intestine into individual amino 
acids and then absorbed by the small intestine. Beyond the essential amino acids required for 
adults, certain amino acids are conditionally essential, i.e. during fetal development and in 
prepubescent children.  Prepubescent children need cysteine, taurine, tyrosine and arginine in 
their diets because they have not reached full metabolic capacity to synthesize these amino 
acids from the essential amino acids [81]. During fetal development cysteine, glutamine, proline 
and arginine are all required for proper organ development, particularly during neurulation 
[82].  
1.3.2 Amino Acids Regulating Physiological and Developmental 
Processes 
Beyond their function as simple nutrients required to assemble new proteins, amino acids 
are also known regulators of many physiological processes. For example, when leucine or 
tryptophan is absorbed they act as a satiety signal to the brain, lowering the desire to find and 
consume food [83].  Amino acids also act as nutrient availability signaling molecules. Plasma 
amino acid concentrations, particularly leucine concentrations, regulate global protein 
synthesis rates and keep those rates in step with amino acid availability [84].  For example, 
amino acid deprivation increases the phosphorylation of eukaryotic initiation factor 2α, a major 
21 
 
component of the cell’s protein synthesis machinery,  slowing protein synthesis rates [82]. 
Conversely, after plasma leucine levels rise (post-feeding), the mammalian target of rapamycin 
(mTOR) signaling pathway responds and phosphorylates its main downstream targets: 
eukaryotic initiation factor 4 binding protein 1 (4E-BP1; when unphosphorylated it binds and 
prevents eukaryotic initiation factor 4 from functioning, slowing protein synthesis) and p70 
ribosomal S6 kinase 1 (p70S6K1; a protein kinase that increases protein synthesis rates when it 
is phosphorylated) [85].  
Concentrations of the individual amino acids have been implicated as regulators of 
preimplantation development and implantation [86].  With glutamine supplementation the 
percentage of embryos in culture that made it to the blastocyst stage, blastocyst cell number, 
percentage of successful hatching blastocyst where all significantly higher [87].  Studies using 
minimal culture media to demonstrate that addition of certain non-essential amino acids (such 
as glutamine and taurine) can drastically increase blastocyst yield, the yield of hatching 
blastocysts and successful establishment of pregnancy of embryos upon introducing them into 
a receptive female [88].  A reduced dead cell count and increased blastocyst cell numbers were 
observed when both essential and non-essential amino acids were added to culture media, 
suggesting that they promote development in human embryos [89].  Finally, amino acids have 
been shown to regulate mouse trophectoderm differentiation, possibly part of the regulation 
pathway for the blastocyst adhesion phase and/or motility (part of the invasion phase) [86, 90].  
Integral to understanding how amino acids can act as regulators is the means by which they are 




1.3.3 Amino Acid Transporter Nomenclature 
All membrane spanning substrate transporters, including all amino acid transporters, have 
been classified into solute carrier families based on their sequence homology. Sequences with > 
25% amino acid sequence identity have been grouped into the same transporter family [91]. 
Currently there are 298 transporters grouped into 43 families [91].  A nomenclature scheme 
was proposed which uses a superscript addition operator (+) to indicate preference for cationic 
forms of amino acids, and a superscript subtraction operator (-) to indicate preference of the 
system for the anionic form of an amino acid, and a superscript 0 to indicate preference for 
neutral amino acids [92, 93].  Subscript letters (A, G, C) are used to indicate preference for 
individual amino acids. Finally, names are capitalized (i.e. ATB instead of atb) to indicate the 
transporter is sodium dependent [94]. For example, System B
0,+
 is a sodium-dependent and 
chloride dependent neutral and cationic amino acid transporter.  
System B
0,+
 was originally described by its activity and later the protein responsible for this 




 is of a coded for by the gene Slc6a14.  Slc6a14 
is an abbreviation designating this gene as member 14 of solute carrier family 6, which are the 
sodium and chloride ion dependent transporters [95].  
1.3.4 Expression and Regulation of Amino Acid Transporters 
Amino acid transporters are expressed on the plasma membrane of every cell and in the 
membranes of various organelles within cells (notably the Golgi apparatus, mitochondria and 
the chloroplasts of plant cells) [91].  They are membrane-spanning proteins in that they have 
hydrophobic transmembrane alpha helices which connect the inner and extra-membrane 
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regions of the transporter protein. A large proportion of amino acid transporters are expressed 
in the small intestine, the main absorptive surface in most species, and they have been 
reviewed by Broer et al. [96].  Most amino acids are moved into the body in the small intestine 
by sodium-dependent amino acid transporters. Sodium-dependent amino acid transporters 
bind sodium ions and amino acids and then move them across the basolateral surface of the 
epithelial cells which line the intestine using the electrochemical gradient of sodium across the 
epithelium [96].  Therefore, their activity can also be altered by a shift in the extracellular 
concentration of the co-transported ion (i.e. sodium). In addition, their activity can be altered 
by accessory protein binding. Amino acid transporter expression can also be regulated at many 
levels, such as the transcription level, post-transcription level, translation level and post-
translation level.   Furthermore, the transporter protein must be moved to and integrated into 
the cell membrane before it is active.  
1.3.5 Amino Acid Transporter Expression Changes during Development 
 Intrauterine growth restriction (IUGR) is a condition characterized by the embryo failing 
to reach its maximum growth potential [97]. IUGR babies are born underweight and can suffer 
from many peri-natal, post-natal disorders and late onset adult diseases like those described by 
the DOHaD hypothesis [98].  IUGR can be induced in rats using a maternal low protein diet [99].   
Changes in amino acid transporter expression and activity have been linked to IUGR.  
When rats were fed a low protein diet throughout pregnancy both the activities and expression 
of System A and System X
-
ag  fell [100], and in particular,  placental uptake of lysine (a preferred 
substrate of System A) was reduced by about 40% across both sides of the syncitium [101].  In 
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rats fed a low protein diet down regulation of some amino acid transporters in the placenta 
actually precedes the onset of IUGR. In particular, the System A isoform Slc38a2 had 
transcription levels that were only 20% of normal at gestational days 19 and 21, before IUGR 
was detectable [98].  Chemical inhibition of System A and System X
-
ag in pregnant rats also 
causes IUGR [103].  A human IUGR study found that expression of the amino acid transporter 
TAUT is reduced in full term IUGR placenta [97]. In contrast, a study using material from human 
pregnancies complicated by Type I Diabetes (i.e. large for gestational age fetuses) found that 
System A transport was increased in that tissue [102]. The decrease in expression and activity of 
these amino acid transporters caused by maternal protein restriction would lead to a lowered 
intracellular level of their substrate amino acids which may cause developmental 
reprogramming.  Therefore, it is conceivable that a similar shift in amino acid transporter 
expression rates could be occurring even earlier, in the preimplantation embryo, from dams fed 
a protein restricted diet, slowing growth and leading to disease-prone adult phenotypes. 
 Placental amino acid transporters are carefully regulated to balance the maternal supply 
with the fetal demand for nutrients [104]. When this balance is upset, fetal growth rates 
respond, leading to increased or decreased fetal weights, and then, much later, adulthood 
diseases [6]. In mice lacking the placental Igf2 promoter (Igf2 P0
+/-
) only placental (not fetal) 
Igf2 expression is eliminated. Placental growth in these mice was greatly reduced compared to 
wild type mice. However, fetal growth is normal until late gestation, suggesting the placenta 
was adapting at a functional level to increase nutrient transfer and maintain fetal growth rates 
[105]. A follow up study found that, in these Igf2 P0
+/-
 mice, fetal nutrient demand exceeded 
maternal supply and the placenta responded to protect the fetus by upregulating transcription 
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of the System A isoform Slc38a4 [106].  When both placental and fetal Igf2 activity was 
completely abolished in a knockout model, this upregulation effect vanished [106], suggesting 
fetal Igf2 is directing the placenta to upregulate transcription of System A (and likely other 
nutrient transporters) to maintain or increase fetal growth rates. Therefore, it is logical to look 
for changes in amino acid transporter expression in response to maternal nutrient restriction in 




1.4 System B0,+ 
System B
0,+
 transports 18 of the 20 amino acids used by the body to construct proteins and 
has the ability to concentrate substrates up to 1000-fold [107]. It is expressed in a few 
pharmacologically relevant tissues (such as the lungs and kidneys) and is being evaluated as a 
possible drug delivery route [108].  In addition, it has been identified as one of the amino acid 
transporters upregulated in colon cancer [109] and cervical cancer [110] and is possibly 
upregulated in many other cancer types [111]. These features make it a potential transporter 
for new cancer chemotherapy drugs [111].  System B
0,+
 has recently been implicated in mercury 
poisoning as it readily transports environmentally common mercury-conjugates into the 
kidneys [112]. Its gene, Slc6a14, has also been linked to obesity; a comparative genomics study 
of over 1700 Finnish and Swedish individuals showed significant differences in the allele 
frequencies in individuals from the obese group when compared to those from the control 
group [113]. They theorize that varying Slc6a14 alleles may code for transporter proteins that 
differ slightly in their rate of tryptophan transport, affecting tryptophan’s availability for 
serotonin synthesis and therefore affecting appetite control. Gestational regulation of amino 
acid transport across the placenta is extremely important for proper fetal growth and 
development and ATB
0,+
 has been found on the maternal-facing microvillous surface of the 
placenta from day 14 onwards in rat gestation [114].   
1.4.1  Regulation of System B0,+ Activity and Expression 
There are no known accessory proteins or other ligands associated with System B
0,+
 
regulation and very little is known about its regulation in general.  Hypothetically, an increase in 
extra-cellular sodium levels would stimulate an increase in sodium uptake (and therefore amino 
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acid uptake) by System B
0,+
 [115].  ATB
0,+
 can be regulated at the transcriptional level.  In 
colorectal cancer cells isolated from patients ATB
0,+
 mRNA levels were found to be 23-fold 
higher than healthy colon cells from the same patients [109].  In a human intestinal epithelial 
cell line, CaCo-2, treatment with cholera toxin causes a 2-fold increase in ATB
0,+
 mRNA levels 
[116].  Cervical carcinoma cells show a 5.6-fold increase in ATB
0,+
 mRNA levels when compared 
to normal cervical cells [110]. Taylor et. al. found that amino acid supplementation causes 
adaptive regulation (both up & down regulation) of ATB
0,+
 expressed in a Xenopus laevis oocyte 
system and that cycloheximide (which inhibits translation) and actinomycin D (which inhibits 
transcription) inhibit this adaptive regulation response [117]. All of the above suggest that 
System B
0,+
 can be regulated at the transcription level. 
1.4.2  System B0,+ and Early Development 
It is well established that the developing embryo is sensitive to its environment and there is 
evidence that blastocyst trophectoderm cells will not become motile in vitro without adequate 
amino acids present in the surrounding environment [86, 118, 119]. However, the link between 
amino acid signaling and trophoblast motility/invasion remains unclear.  Martin et al. found 
that trophoblast motility is dependent on the availability of exogenous amino acids, which 
signal trophectoderm differentiation and the gain of motility about 20 hours before 
implantation [86, 90].   System B
0,+
  has been linked to this amino acid uptake by Van Winkle et 
al. [120].  He theorized that preimplantation and periimplantation blastocysts are ‘poised’ to 
take up leucine; when placed in media which is rich in amino acids they rapidly accumulated 
leucine, more than even their in vivo counterparts [120]. There is evidence to suggest that 
leucine and isoleucine in particular are rapidly brought into the pre-motile cells and this signals 
28 
 
the cells to start synthesizing the proteins necessary for normal motility and uterine wall 
penetration [86].   
Rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR) nutrient sensing 
pathway, blocks development of blastocyst motility which is thought to control translation of 
proteins necessary for motility and invasion [90].  Rapamycin, a macrolide, acts as an 
immunosuppressant and an antibiotic and suppresses mTOR activity [121, 122].  Leucine is a 
known stimulator of the mTOR pathway [85, 123].   Disruption of the mTOR gene is an 
embryonic lethal mutation which is lethal just after implantation [124, 125]. It appears that 
without mTOR signaling the trophectodermal cells are unable to proliferate further after 
implantation, and furthermore, the embryonic stem cells (a.k.a. the inner cellular mass) fail to 
proliferate beyond implantation [124, 125]. This is in consistent with Martin et al.’s in vitro 
observations that both rapamycin (a known inhibitor of mTOR) and leucine deprivation prevent 
development of motility and outgrowth of embryos [86, 90, 118, 119].  Interestingly,  in the pig, 
a mammalian species that does not exhibit penetrative implantation [126], system B
0,+
 is not 
expressed during implantation [127]. This suggests that species that do not utilize penetrative 
implantation would not be sensitive to leucine deprivation during preimplantation 





The mechanisms underlying the DOHaD hypothesis remain largely unknown. Epigenetics 
have been implicated, but how the extracellular environment prompts epigenetic changes 
remains unclear.  The nutrient sensitive mTOR pathway controls translation of approximately 
52% of the human proteome and is likely involved in the translation of enzymes which change 
the epigenetic status of the cell [121].  It has been shown that System B
0,+
 shows a preference 
for tryptophan and leucine -- upstream signalers of the mTOR pathway [128].  It is possible that 
mTOR could respond to changes in leucine concentration brought about by changes in System 
B
0,+
 activity and/or expression. Downstream effects of this response could lead to long term 
physiological changes in the developing organism. Therefore, investigating System B
0,+
 
expression during preimplantation development could help to explain the physiological changes 
observed in DOHaD research. To that end, this study aims to investigate the effects of a 





2. Materials and Methods 
2.1 Animals 
Virgin female Wistar rats (n=14) were maintained in a temperature-controlled room 
with a 12h light/dark cycle.  The colony was kept in the University of Waterloo Biology Animal 
Care Facility. This room had time-controlled lighting which starts the dark cycke at 3pm.  The 
colony’s food was administered twice a week and was never allowed to become depleted. At 
approximately 6 months of age females were mated overnight with males of the same strain.  
After a vaginal plug was detected the male was removed and the female was randomly 
assigned to a diet group; either the 9% casein (low protein diet) or a 18% casein (control diet). 
The low protein diet was selected based on previous research by Kwong et. al. [21].  The diets 
were provided by Harlan Teklad (Harlan Laboratories; Indianapolis, IN., U.S.A.)  and their 




 Table 1. Comparison of the 18% and 9% Casein-based diets. 
Diet Details Control Low Protein 
Casein (g/Kg) 180.0 90.0 
DL-Methionine (g/Kg) 5.0 5.0 
Sucrose (g/Kg) 198.0 228.0 
Corn Starch (g/Kg) 325.0 385.0 
Maltodextrin (g/Kg) 95.0 95.0 
Corn Oil (g/Kg) 100.0 100.0 
Cellulose (g/Kg) 50.0 50.0 
Mineral Mix (AIN-76) (g/Kg) 35.0 35.0 
Vitamin Mix (AIN-76A) (g/Kg) 10.0 10.0 
Choline Bitatrate (g/Kg) 2.0 2.0 
 
After being assigned to a diet group the date was recorded and noted as “Day 0” of 
gestation, setting the start time of gestation (conception) at approximately 4am that day [129], 
due to their night starting at 3pm the prior day. At day 4.25 (4d, 6h), 10am on day 4 of 
gestation, the animals were euthanized for blastocyst collection. Both the dam’s weight and 
remaining food weight was recorded at this time. This gestational age was selected for the 
following reasons: there is elevated System B
0,+
 activity in mice embryos at this stage [120], 
evidence suggests that System B
0,+
 mRNA expression peaks in mouse preimplantation embryos 
at this stage [86], after ~4.25 days rat blastocysts quickly hatch and  begin attaching to the 
uterus; making them extremely difficult to retrieve [130] and previous DOHaD research 
suggesting exposure to a protein restricted diet for this precisely this length of time is enough 
to cause an altered phenotype [21, 131]. 
2.2 Blastocyst Collection 
Blastocysts were collected from the euthanized animals using a modified version of an 
established protocol [132]. First, the animal was opened and the uterus exposed. Then a cotton 
swab dipped in 0.9% saline was used to clean the vagina.  A polyurethane tube (5mm inner 
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diameter, 10cm in length) was inserted into the vagina. 400 μl of phosphate buffered saline 
(PBS, 0.01M Na2HPO4, 0.0027M KCl and 0.137M NaCl, pH = 7.4) containing 3 mgl/ml bovine 
serum albumin (BSA, Sigma-Aldrich Canada Ltd., Oakville, Ontario), was then injected into each 
uterine horn using a 25 gauge, half-inch long needle. The needle was inserted into the lumen of 
each uterine horn pointed upwards towards the oviduct so that the entire contents of the 
uterine horn could be flushed down and out into the tubing. The flushing medium was then 
collected in a customized embryo collection dish (5cm Plexiglas doweling, sliced into a 8mm 
thick plate, with a convex 4mm divot in the center; created by Mr. Harmen Vander Heide, 
Science Technical Services) and then examined under a dissection microscope (Nikon SMB-2B). 
The photograph below shows an animal prepared for blastocyst collection. 
 
  Figure 3. Photograph of the blastocyst collection method. The embryo   
  collection dish (bottom-left) is placed under the tubing to catch the flushing  




The blastocysts were quickly collected using the dissection microscope with a 10μl 
micropipette and removed from the flush media. They were then passed through a series of 
four 25μl droplets of washing solutions; two droplets of phosphate buffered saline (as above) 
containing 4mg/ml of polyvinyl pyrrolidione (PVP, Sigma-Aldrich Canada Ltd., Oakville, Ontario) 
and two clean droplets of flushing media. The polyvinyl pyrrolidione was used to reduced 
blastocyst stickiness, so that they could be separated and analyzed individually [133]. After 
washing, the individual blastocysts were then immediately passed through a nucleic acid 
recovery kit.  
2.3 DNA and RNA Recovery 
DNA and RNA recovery from the blastocysts was then carried out using the Norgen 3-in-
1 DNA/RNA/Protein extraction kit. (Norgen Biotek Corp.; Ontario, Canada) This kit uses spin-
columns with a proprietary membrane designed to bind nucleic acids.  However, the normal kit 
protocols were modified to extract RNA and DNA from extremely small samples.  First, the 
blastocyst was lysed in 300μl (reduced from 600μl) lysis buffer containing 3μl β-
mercaptolethanol. This was done using a vortex mixer set on high for 60 seconds. Then 300μl of 
95% ethanol (up from 75%) was added to this mixture, which is passed through the spin-column 
using a microcentrifuge. Then, two RNA wash buffer steps are performed to clean the column. 
Finally, the RNA is eluted using RNA elution buffer. The genomic DNA (gDNA), still on the 
column, is cleaned with a wash buffer and then eluted using an elution buffer. The gDNA was 
frozen at -20°C and the RNA was placed on ice to be immediately reverse-transcribed to cDNA. 
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2.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
The RNA was reverse transcribed to cDNA using the Qiagen Quantitect Reverse 
Transcription Kit (Qiagen; Germantown, Md., U.S.A.) following the kit instructions. cDNA 
synthesized from blastocysts was then amplified with PCR using established rodent ATB
0,+
 and 
Hprt primers to verify that RNA recovery and cDNA synthesis steps were successful.  
Hypoxanthine-guanine phosphoribosyltransferase (Hprt) is a metabolic enzyme with a low basal 
expression rate in all tissues and was selected as a reference gene to use to evaluate ATB
0,+
 
expression. The Qiagen HotStarTaq Plus Kit (Qiagen; Germantown, Md. U.S.A.) was used to 
prepare a standard 20μl mastermix: 1U Taq, 2μl 10x PCR Buffer, 10.6μl water, 0.4μl dNTPs, 2μl 
(0.5μM) of each primer pair member and 2μl of blastocyst cDNA. This was loaded into a 
thermocycler (GeneAmp PCR 9700, Applied Biosystems; Carlsbad, Ca. U.S.A.) and run through 
the following program:  one 5 minute activation step at 95°C, followed by 45 standard cycles 
(45 seconds at 94°C, 45 seconds at 58°C and 1 minute at 72°C) plus a final extension time of 10 
minutes at 72°C.  Below are the primer sequences used for both cDNA verification (using RT-
PCR) and then again for assessing ATB
0,+
 expression (using quantitative real-time polymerase 
chain reaction; qRT-PCR). 
Table 2. Primers used for both PCR and subsequent qRT-PCR cDNA evaluation. 
Target 
Gene 
Upstream Primer Downstream Primer Product 
Size Ref 
ATB0,+ 5'-ACTTTGCCTTCTTCTAGCTT-3' 5'-TGAGAATCCAGACCCAATGT-3' 551bp [134] 
Hprt 5'-GCTGAAGATTTGGAAAAGGTG-3' 5'-AATCCAGCAGGTCAGCAAAG -3' 157bp [135] 
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2.5 Quantitative Real Time Polymerase Chain Reaction (qRT-PCR) 
 After the cDNA had been verified as outlined above it was analyzed with qRT-PCR using 
Qiagen’s QuantiTect SYBR Green PCR Kit (Qiagen; Germantown, Md. U.S.A.) and the University 
of Guelph’s Core-lab facility Roche Lightcycler 3 (Roche Ltd.; Basel, Switzerland) qRT-PCR 
thermocycler.  The same primers used above in cDNA verification were used to evaluate ATB
0,+
 
expression using Hprt as the reference gene. A mastermix was created using 12μl Qiagen SYBR 
Green mastermix, 1μl (final working concentration of 1.5μM) of magnesium-chloride (MgCl), 
2μl (0.5μM) of each primer pair member, 1μl water and 2μl of blastocyst cDNA. Each sample 
was amplified in duplicate using both sets of primers. Afterwards, melting curves were acquired 
by incrementally increasing the temperature from 55°C to 95°C to ensure that a single product 
was amplified in the reaction. A dilution series of PCR product was created by amplifying pooled 
embryo cDNA and then diluting the resulting product down to 10
-10
 in ten-fold increments. 
Then, a co-efficient file containing cycle number and cross-over points for each dilution in the 
dilution series was created using Roche’s RelQuant (Roche Ltd.; Basel, Switzerland) software 
and applied to all generated data to normalize between runs to control for minute inter-run 
variances in mastermix volumes and concentrations. To ensure that the qRT-PCR amplification 
is in the linear range and the correct cross-over points are identified, the LightCycler 3 software 
(Roche Ltd.; Basel, Switzerland) automatically defines the threshold fluorescence value by 
assessing the second derivative maximum of each amplification curve to calculate the initial 
gene copy number in the sample. The resulting calculated values are a ratio of the cross-over 
points (where fluorescence exceeded the threshold value, which is determined automatically 
by the software) of ATB
0,+
 to Hprt. 
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2.6 Blastocyst Gender Determination using Nested PCR 
Nested PCR with primers for the Sry, Zfy and Hprt genes were used to determine 
blastocyst gender. It uses two sets of primers in two successive PCR runs with the second 
primer set, the “inner primers”, intended to amplify a target sequence within the sequence 
produced in the first PCR reaction using the “outer primers”.  The detailed method was 
published by Fleming et al. in 2002 [136]. The Sry (Sex determining Region of the Y-
Chromosome) and Zfy (male germ cell development) genes are found only in males, but there 
may be similar sequences on other chromosomes.  This is because both Sry and Zfy are high 
mobility group (HMG) transcription factors and therefore share a great deal of sequence 
identity with other transcription factors in the same family [137]. Nested PCR eliminates false 
positives from these similar sequences since any mis-primed product formed in the first round 
of amplification should not amplify in the second round of amplification. The third primer set, 
Hypoxanthine-guanine phosphoribosyltransferase (Hprt), is used as a positive control for the 
presence of genomic DNA in a sample. In a female sample only Hprt product will amplify, since 
Zfy and Sry are not present in female samples. Nested PCR also increases PCR sensitivity one 
thousand fold and has a proven track record of sexing preimplantation embryos [138].  
Genomic DNA recovered from the blastocysts was extremely diluted in 100μl of the 
elution buffer used during extraction. This was concentrated down to 20μl using a 
microcentrifuge concentrator set on high for 20 minutes. Then, a 50μl outer PCR reaction 
mixture was prepared. It was comprised of: 20μl of the concentrated genomic DNA sample, 
2.5μl (2.5U) of Taq polymerase, 1μl dNTPs, 3.3μl(0.5μM) of each of the 6 outer primers, 5μl of 
10x PCR Buffer and 1.5μl of water. The nested PCR program conditions used were as follows: 30 
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cycles of 94°C for 1min, an annealing step at 60°C for 2.5min and an extension step at 72°C for 
2.5min.  A final extension time of 10 minutes at 72°C was performed afterwards. Product from 
the outer primers was then used as a template for the second, or “inner”, PCR reaction. Two 
separate 20μl inner PCR reaction mixtures were created; one with the Hprt and Zfy inner 
primers, and another with the Sry inner primers. They were comprised of: 1ul (1U) of Taq 
polymerase, 2μl 10x PCR Buffer, 0.4μl dNTPs and 2μl of each inner primer pair member 
(working concentration of 0.5μM), 2μl of outer PCR product DNA (as the template material) and 
water to top the reaction mixture up to 20μl. The 2 resultant PCR reaction products from the 
second round of amplification are then run out on a 1.5% agarose gel. If Zfy and Sry bands were 
detected, the sample was scored as a male. If only Hprt was detected, the sample was scored as 





Table 3. Primers to be used for nested PCR gender determination. 




5'-CACAAGTTGGCTCAACAGAATC-3' 5'-AGCTCTACTCCAGTCTTGTCCG-3' 300 
Zfy 
Outer 
5'-AAGATAAGCTTGCATAATCACATGGA-3' 5'-CCTATGAAACCCTTTGCTGCACATGT-3' 611 
Hprt 
Outer 
5'-GTTCTCTTCAATTGCTGGTCCA-3' 5'-TGACAACGATTCACACTGCTGA-3' 618 
Sry 
Inner 
5'-AGCATGCAGAATTCAGAGAT-3' 5'-ATAGTGTGTAGGTTGTTGTCC-3' 248 
Zfy 
Inner 
5'-GGAAGCATCTTTCTCATGCTGG-3' 5'-TTTTGAGCTCTGATGGGTGACGG-3' 207 
Hprt 
Inner 





3.1 Dam Weight Gain and Food Consumption during Early Pregnancy  
Dams were weighed after vaginal plug detection (successful mating) and again at 
euthanasia just prior to embryo collection.  During this time they were given ad libitum access 
to their assigned diet. Upon euthanasia the total food consumption of each dam was recorded. 
There was not a statistically significant difference in the weight gain or food consumption 
between the two diet groups.  
Table 4. Dam Weight Gain and Food Consumption during Early Pregnancy.  The two diet 
groups showed no difference in maternal weight gain or food consumption during early 
pregnancy. Mean dam weight gain was 16.880 ± 2.376g, mean food consumption was 90.543 ±  
5.094g. 
 
MLP Diet (g) 
(9% Casein, n = 7) 
Control Diet (g) 
(18% Casein, n= 7) 
Difference (g) 
Dam Weight Gain 
During Early Pregnancy 
(Mean ± SEM) 
19.3 ± 2.941 14.4 ± 3.716 
4.9 
(p > 0.05) 
Dam Food Consumption 
During Early Pregnancy 
(Mean ± SEM) 
97.6 ± 6.139 83.5 ± 7.626 
14.1 
(p > 0.05) 
Age of Dams at 
Conception 
6.6 ± 0.769 Months 6.3 ± 0.884 Months - 
3.2 Gender Determination of the Recovered Embryos 
Using the outlined nested PCR protocol each blastocyst was assessed with male-specific 
primers targeting X-Chromosome (male) genes. Figure 4 is an image of an electrophoresis gel 
showing the resultant PCR product. Hprt and Zfy PCR products are different sizes (318bp and 
207bp, respectively) and if both bands are present, the sample is male. If only Hprt is present, 
the sample is female. This is demonstrated in the upper half of figure 4. In addition to the Hprt 
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and Zfy primers, Sry-specific primers were used in a separate reaction mixture to confirm a 
sample’s gender. The Sry product (expected size of 248bp) is shown in the bottom portion of 
figure 4. A Zfy product should have corresponding Sry product in the lower part of the gel, 
confirming a male sample.  110 samples were analyzed this way and 108 were assigned a 
gender using this technique; 58 males and 50 females. The remaining two samples did not 
amplify with any primer sets; this probably indicates that no genomic DNA was recovered. In 21 
of these samples either Hprt amplification or Zfy amplification (done in the same reaction 
mixture) out-competed the other and only one product band was visible on the agarose gel; 
these samples were flagged to be rerun using two separate PCR reaction mixtures, one for each 
primer set, to correctly score the sample as male or female.  
 
Figure 4. Blastocyst gender determination (Nested PCR) 
1.5% Agarose Gel. 
Upper half: Each embryo was assessed for the male
serves as an internal positive control to indicate gDNA was present. A double band indicates a 
male sample; a single band indicates a female sample. 
Lower half: The same embryo was assessed for the male
gender.  
Notes: Ambiguous samples were flagged to be rerun. Shadow bands above expected product 
size are likely carry over Nested
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3.3 Relative Expression Rates of ATB
The blastocysts from the MLP diet group showed no significant difference in expression 
levels of ATB
0,+ 
 (relative to Hprt expression) 
This data was then separated 
differences in expression.  Both the male and female data sets showed no significant 
differences in expression. Therefore the MLP diet has no effect on blastocyst expression levels 
of ATB
0,+
 when compared to the control diet. (See Figure 5)
Figure 5. Relative ATB
0,+
:Hprt Expression Rate in rat blastocysts from dams fed either a 
protein restricted or normal diet. 
for gender-related effects.  Blastocysts from the MLP diet fed dams compared to those from 
the control diet fed dams did not show any statistical difference in ATB
relative expression of ATB
0,+
:Hprt
test. (p > 0.05 for all groups) 
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0,+ mRNA to Hprt mRNA 
when compared those from the control diet group.  
into male and female data sets to analyze it for gender specific 
 
Data has been separated by blastocyst gender to examine
0,+
 expression rate. 









 A protein restricted maternal diet had no significant effect on ATB
0,+
 transcription 
relative to Hprt in rat preimplantation blastocysts. This finding suggests that changes in the 
expression of the amino acid transporter System B
0,+
 may not be responsible for the 
developmental reprogramming observed by many researchers, including Kwong et al. [21, 131] 
and Langley-Evans et al. [6].  
 Although the findings were not statistically significant, there does appear to be a trend 
in the data.  From the graph it appears that there is an upregulation of ATB
0,+
 transcription in 
the blastocysts exposed to the MLP in all groupings. This trend is inconsistent with a study 
which found that maternal protein restriction in rats led to reduced transcription rate of System 
A in the placenta preceding IUGR [98]. It is also inconsistent with an earlier study which found 
that maternal protein restriction in rats led to reduction in both the activity and the 
transcription rate of System A during IUGR [100].  However, this trend is consistent with an in 
vitro study wherein a placental cell line was exposed to amino acid restricted conditions. In that 
study System A responded to the decreased substrate availability by increasing its transcription 
rate in order to maximize substrate recovery [139].  In addition, System B
0,+ 
expression in 
Xenopus laevis oocytes is adaptively regulated at the transcription level in response to amino 
acid deprivation [117].  If System B
0,+ 
is exhibiting this adaptive regulation in rat blatsocysts in 
response to the MLP diet then it could be having downstream mTOR signaling effects.  These 
effects could lead to the programming of a predictive adaptive response to the protein 




 It is also possible that while expression levels remain unchanged, the activity of System 
B
0,+
 could be responding to changes in the maternal environment, such as a shift in the uterine 
sodium content. Furthermore, System B
0,+
 translation rates are regulated separately from 
transcription rates, meaning changes in translation (and thus overall activity) wouldn’t be 
visible at the transcription level thus reducing the usefulness of qRT-PCR.  Such changes in 
transporter activity without a corresponding change in transcription have been noted before 
[139]. Insulin-stimulated glucose uptake rates in individual blastocysts has been assessed using 
tritium labeled 2-deoxyglucose [140].  Non-invasive assessment of pyruvate and glucose uptake 
using ultramicrofluorescence techniques is also possible [141]. There are techniques that can 
detect activity changes of amino acid transporter systems in pooled blastocysts [120] and 
theoretically they could be used to assess System B
0,+
 activity in pooled blastocysts taken from 
protein restricted dams.  However, due to the high number (n = 360) of blastocysts required, 
the samples used in these studies came from dams artificially stimulated by gonadotropins to 
produce large litters. The blastocysts used by Van Winkle et al. were also allowed to enter 
diapause first (by ovariectomizing the dams after conception) and then stimulated to develop 
into “implanting” blastocysts with estrogen and progesterone injections administered to the 
pregnant dam [142].  Therefore, the blastocysts recovered from these dams are not necessarily 
analogous to blastocysts recovered from an undisturbed pregnancy, and the activity assays in 
these studies were done in in vitro embryo culture media, which could be very different from in 
vivo conditions. Furthermore, pooling embryos abolishes the ability to detect subtle gender-
specific differences, further reducing the usefulness of activity assays using pooled blastocysts. 
It also eliminates the ability to detect differences between individuals, preventing intra-litter 
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evaluation. However, if System B
0,+
 activity is changing in response to the maternal diet, 
regardless of its expression levels, it could indeed be leading to reprogramming events. 
Therefore, System B
0,+
 activity in individual preimplantation embryos,  while impossible to 
determine with current technology, should be investigated in future studies when more 
sensitive technology becomes available. 
 Protein abundance levels are a potential variable that could affect System B
0,+
 activity. 
Immunostaining techniques exist that could be used to assess protein abundance levels in a 
sample, such as immunohistochemistry and western blotting, which give qualitative 
information about the protein abundance in that sample. These readings must then be 
subjectively evaluated for differences.  At best, the results can be evaluated using computer 
software to compare relative brightness between samples (this is called densitometry). Extracts 
from approximately 100 to 150 blastocysts can be pooled for western blot analysis [143], but 
doing so would make gender determination impossible and might defeat any attempts at 
detecting subtle gender specific differences. Unfortunately there is not enough recoverable 
protein in an individual blastocyst to perform a western blot. Immunohistochemical approaches 
in conjunction with confocal microscopy (together called ‘confocal immunofluorescent 
microscopy’) could theoretically be used to compare System B
0,+
 protein abundance in an 
individual embryo if a proper antibody was available. Unfortunately at present there are no 
suitable antibodies available from a commercial source.  Confocal microscopy is excellent for 
detecting dramatic changes in protein abundance in preimplantation embryos.  For example, in 
preimplantation mouse embryos exposed to hyperglycemic conditions the abundance of the 
GLUT-1 glucose transporter protein was dramatically increased [50]. However this technique 
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isn’t sensitive enough to detect a subtle change in protein abundance levels.     Enzyme-linked 
immunosorbent assay (ELISA) technology is also too insensitive for samples of this size, 
however two technologies that could assess protein abundance levels in small samples are 
HPLC and mass spectrometry. In addition, there is a new technology called plasmon resonance 
which can detect a single molecule of the protein of interest, but for now this technology 
remains prohibitively expensive.  Because of the limited time a masters project affords, and the 
obvious economical reasons, qRT-PCR was selected for this project. However, System B
0,+
 
protein abundance levels should be investigated with some of the aforementioned 
technologies in case they are changing in response to the maternal diet. 
 Quantitative RT-PCR, the technique used for this study, has many inherent weaknesses. 
For example, qRT-PCR yields values that are a ratio of the expression of one gene relative to 
another. This means that if your reference gene is changing just as much as your target gene 
then no difference in expression will be detected. In this study, ATB
0,+
 (Slc6a14) expression was 
compared to Hprt expression. β-actin (Actb; a highly expressed and ubiquitous cytoskeleton 
component) and Hprt are frequently used as reference genes in qRT-PCR studies that use adult 
tissues [135].  However, Hprt is far superior to Actb for qRT-PCR analysis using pre-implantation 
embryos since Actb appears to vary significantly in expression rates throughout pre-
implantation mouse development, whereas Hprt remains constant [144].   Unfortunately, 
nothing is known about the expression of Hprt in rat blastocysts in response to a maternal low 
protein diet. Therefore, it is conceivable that Hprt is responding to the diet, ending its 
usefulness as a reference gene.  ATB
0,+
 expression could be changing in relation to other 
reference genes and this should be investigated. However, assuming that the reference gene is 
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not changing in response to experimental conditions, quantitative RT-PCR is a very powerful 
technique as it provides a relative mRNA copy number present in a given sample and it is 
sensitive to changes in a large range of starting material concentrations ( >5 orders of 
magnitude) [145], making it extremely useful for expression comparison studies using limited 
amounts of sample material. 
 It would be valuable to know what epigenetic changes result from a protein restricted 
diet in the preimplantation embryo. Although there is a limited amount of genomic DNA 
available for such analyses, techniques like carrier chromatin immunoprecipitation and micro-
arrays (“ChIP-on-chip”) can be used to evaluate the epigenetic status of blastocyst DNA [146]. 
Indeed, there is evidence that certain loci, particularly those near the imprinted Igf2 locus, have 
dramatically altered DNA methylation patterns when exposed to an insufficient maternal 
dietary conditions  [147].  There are likely many hundreds of genes being affected at the 
epigenetic regulation level due to maternal diet perturbations waiting to be discovered using 
this technology.  
 System B
0,+
 was investigated in part because its preferred substrate, leucine, is a known 
upstream signaler of the mTOR pathway [85]. Preimplantation mouse embryos exposed to 
either amino acid deprivation or rapamycin (an mTOR inhibitor) in vitro do not develop the 
normal cellular outgrowths usually associated with implantation [90].   However, there are 
many other upstream signalers of mTOR such as insulin, growth factors and oxidative stress 
[121]. In order to fully understand the mTOR pathway and if it is affecting fetal programming 
we need to first establish that its activity is indeed changing in preimplantation embryos 
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exposed to a protein restricted maternal diet.  This has not been examined in rat 
preimplantation embryos exposed to a MLP diet, but it has been established that mTOR activity 
is altered in the placenta during maternal under nutrition [148], so it seems likely. This could be 
done using immunohistochemcial approaches to detect increased phosphorylation of mTOR’s 
downstream targets S6K1 and 4EBP1. Previous studies have shown at S6K1 and 4EBP1 
phosphorylation changes in a variety of cell types [2, 3, 149].  This work was originally proposed 
as a part of this study and needs to be done to determine how mTOR in blastocysts is 
responding to the maternal diet. 
 The changes in maternal serum amino acid concentrations during MLP conditions have 
been documented extensively. High Performance Liquid Chromatography (HPLC) is a well 
developed and broadly used technique that can measure free amino acid and carbohydrate 
concentrations in a sample.  HPLC has been used to assess maternal serum amino acid 
concentrations from rat dams exposed to the MLP diet during early pregnancy (from 
conception to day 4 of gestation).  In the serum of MLP dams there was a significant increase in 
glutamine concentrations and a decrease in isoleucine, leucine, methionine, proline and 
threonine concentrations [21].  Leucine levels in particular dropped by about 10% [21].  In other 
rat studies, restricted protein during early pregnancy was shown to decrease serum 
concentrations of threonine [150], increase maternal serum concentrations of glutamine and 
glycine, and most importantly, decreased maternal serum concentrations of the branched-
chain amino acids (leucine, isoleucine and valine) [151]. In pregnant mice, a maternal low 
protein diet reduces serum concentrations of the amino acids phenylalanine, leucine, isoleucine 
and valine and these decreases lead to IUGR [152].   
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 These changes in maternal serum amino acid concentrations in response to a protein 
restricted diet need to be experimentally connected to changes in the amino acid 
concentrations in the uterine fluids.  Some work has already been done with uterine luminal 
fluid: uterine luminal fluid extracted from mice has been compared to in vitro embryo culture 
media [153] and the normal uterine secretions of rabbits during preimplantation development 
[154] have been described.  Throughout rabbit preimplantation development uterine amino 
acid concentrations change considerably.  For example, leucine drops to about 40% of its initial 
concentration by the blastocyst stage [154]. If the maternal diet is causing a reduction in 
uterine leucine concentrations (corresponding with the previously described serum 
concentrations reductions, above) throughout preimplantation development it has strong 
implications for System B
0,+
 activity.  System B
0,+
 activity is logically dependent on the 
concentrations of its substrates in the external medium and reducing System B
0,+
 activity would 
result in lowered intracellular leucine availability. This in turn would alter mTOR activity and 
could potentially cause a predictive adaptive response. 
 Predictive adaptive responses could potentially be programmed for by changes in the 
DNA methylation pattern of a preimplantation blastocyst. The preimplantation embryo is 
particularly sensitive to methyl donor availability; during preimplantation development the 
genome is demethylated and the proper methylation pattern of all genes is then established 
[60].  Methionine’s derivative S-adenosyl methionine is the “universal methyl donor” and 
serves as the primary methyl donor for these reactions. In the MLP fed dams methionine serum 
levels were markedly reduced [21]. It is then logical to expect a reduction in uterine luminal 
fluid methionine levels.  Interestingly, in adult rat studies, methionine deprivation or 
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supplementation caused a 4 fold and 2.8 fold (respectively) increase in transcription of a liver 
methionine cycle enzyme, betaine-homocysteine methyltransferase (BHMT) [155, 156].  BHMT 
catalyzes the transfer of a methyl group from betaine to homocysteine; ultimately producing 
methionine [157].  It has been detected in human oocytes [158] and is probably present 
throughout development to maintain the supply of methyl donors for the rapidly developing 
embryo.  BHMT expression and activity is directly linked to methyl donor availability and if it is 
responding to a protein restricted diet in preimplantation embryos it could provide a valuable 
clue indicating that the MLP diet is indeed affecting methyl donor availability and potentially 
the methylation pattern of the developing embryo. 
 The existence of predictive adaptive responses, as described by the DOHaD hypothesis, 
is supported by more and more evidence as time passes. However, the mechanisms that cause 
these adaptive responses remain unexplained. While no significant difference in ATB
0,+
 
transcription was noted, the upward trend seen in this research warrants further investigation. 
System B
0,+
 activity in response to the MLP regime also remains a mystery and further 
investigation into the nutrient sensing mTOR pathway will likely provide additional insights. 
There is still much work to be done and uncovering System B
0,+
’s roll in preimplantation 
development and its possible roll in predictive adaptive responses has only just begun. 
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Appendix A: Raw qRT-PCR Results  
(Expression of ATB0,+ : Hprt observed in individual embryos) 
The relative expression values of ATB
0,+
 : Hprt for the individual blastocysts are 
tabulated below. (4 tables: MLP males, control males, MLP females and control females) 
Table 5. Relative expression of ATB0,+ : Hprt in male blastocysts  
from dams fed the MLP (9% casein) diet. 
Dam #: 1 2 3 4 5 6 7 
Embryo 1 0.1420 0.0020 0.0609 0.0003 0.1450 0.0327 0.0193 
Embryo 2 0.2900 0.0003 0.0468 0.0000 0.0147 0.0281 0.0006 
Embryo 3 0.0000 0.0000 0.0146 0.0020 0.0356 0.0011 0.0896 
Embryo 4 0.0000 0.0006 0.0353 0.7200 0.0063     
Embryo 5   0.0033 0.0160 0.0002       
Embryo 6   0.0046 0.0853         
Mean 0.1080 0.0018 0.0432 0.1445 0.0504 0.0206 0.0365 
 
Table 6. Relative expression of ATB0,+ : Hprt in male blastocysts  
from dams fed the control (18% casein) diet. 
Dam #: 1 2 3 4 5 6 7 
Embryo 1 0.0022 0.0066 0.0114 0.0050 0.0012 0.0119 0.0005 
Embryo 2 0.0208 0.0897 0.0060 0.0007 0.0012 0.0101 0.0000 
Embryo 3 0.0001   0.0101 0.0013   0.0311 0.0001 
Embryo 4 0.0008   0.0200 0.0050   0.0041 0.0009 
Embryo 5     0.4310 0.1790     0.0000 
Mean 0.0060 0.0482 0.0957 0.0382 0.0012 0.0143 0.0003 
 
Table 7. Relative expression of ATB0,+ : Hprt in female blastocysts  
from dams fed the MLP (9% casein) diet. 
Dam #: 1 2 3 4 5 6 7 
Embryo 1 0.0000 0.0024 0.0719 0.0000 0.0620 0.0005 0.0015 
Embryo 2 0.0000 0.1550 0.0194 0.0102 0.0121 0.1500 0.0000 
Embryo 3 0.0000     0.0291 0.0586 0.0022 0.0461 
Embryo 4         0.1790 0.0028 0.0020 
Embryo 5           0.0303 0.0025 






Table 8. Relative expression of ATB0,+ : Hprt in female blastocysts  
from dams fed the control (18% casein) diet. 
Dam #: 1 2 3 4 5 6 7 
Embryo 1 0.0147 0.0056 0.0102 0.0034 0.0010 0.0124 0.0001 
Embryo 2 0.0163 0.0116 0.0009 0.0170 0.0016 0.0277 0.0008 
Embryo 3 0.0496 0.0385 0.0180 0.0357 0.0011 0.0707   
Embryo 4 0.1110 0.0103     0.0014 0.0359   
Embryo 5   0.0029     0.0012     
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